Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-07
DOI
10.1002/onco.13627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs
- (2020) Hye Yeon Choi et al. Nature Communications
- Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells
- (2019) Christian B. Lessard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
- (2018) Natalie Cook et al. BRITISH JOURNAL OF CANCER
- Dynamic Ligand Discrimination in the Notch Signaling Pathway
- (2018) Nagarajan Nandagopal et al. CELL
- A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours
- (2018) Kyaw L. Aung et al. INVESTIGATIONAL NEW DRUGS
- Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway
- (2018) Long Hai et al. Cell Death & Disease
- Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
- (2018) Shin-ichi Tsukumo et al. Frontiers in Immunology
- Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?
- (2018) Mahnaz Janghorban et al. Frontiers in Immunology
- Notch Signaling in the Tumor Microenvironment
- (2018) Olivier Meurette et al. CANCER CELL
- The Many Substrates of Presenilin/γ-Secretase
- (2018) Annakaisa Haapasalo et al. JOURNAL OF ALZHEIMERS DISEASE
- Gamma-secretase-dependent signaling of receptor tyrosine kinases
- (2018) Johannes A.M. Merilahti et al. ONCOGENE
- Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma
- (2018) Xuran Yang et al. Oncotarget
- Gamma secretase inhibitors: a patent review (2013 - 2015)
- (2017) Kai Gu et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)
- (2017) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
- (2017) Keith M. Skubitz MAYO CLINIC PROCEEDINGS
- Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines
- (2017) M.C. Pazos et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma
- (2017) Katherine M. Morgan et al. MOLECULAR CANCER THERAPEUTICS
- Practice Bulletin Number 179
- (2017) OBSTETRICS AND GYNECOLOGY
- Notch Signaling in Development, Tissue Homeostasis, and Disease
- (2017) Chris Siebel et al. PHYSIOLOGICAL REVIEWS
- HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
- (2017) Lei Sun et al. Journal of Cancer
- Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
- (2016) D. Peng et al. CANCER RESEARCH
- Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells
- (2016) Jiesi Zhou et al. CELLULAR SIGNALLING
- Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
- (2016) R. Xu et al. CLINICAL CANCER RESEARCH
- A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
- (2016) Shubham Pant et al. EUROPEAN JOURNAL OF CANCER
- Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752
- (2016) XiuXiu Chen et al. GYNECOLOGIC ONCOLOGY
- Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer
- (2016) Yasuyuki Ikezawa et al. International Journal of Clinical Oncology
- Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
- (2016) Edward Pan et al. JOURNAL OF NEURO-ONCOLOGY
- Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
- (2016) Tanya Stoyanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
- (2016) Marzia A. Locatelli et al. Oncotarget
- Targeting theNotch pathway: A potential therapeutic approach for desmoid tumors
- (2015) Hui Shang et al. CANCER
- Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
- (2015) Lindsey M. Hoffman et al. CHILDS NERVOUS SYSTEM
- Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer
- (2015) Hyun-Woo Lee et al. CLINICAL & EXPERIMENTAL METASTASIS
- HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer
- (2015) Ruixue Yuan et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
- (2015) E. G. Chiorean et al. CLINICAL CANCER RESEARCH
- Notch Pathway Inhibition Using PF-03084014, a -Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer
- (2015) D. Cui et al. CLINICAL CANCER RESEARCH
- A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
- (2015) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- Increased Notch1 Expression Is Associated With Poor Overall Survival in Patients With Ovarian Cancer
- (2015) Ahmed Numan Alniaimi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- γ Secretase Inhibitor BMS-708163 Reverses Resistance to EGFR Inhibitor via the PI3K/Akt Pathway in Lung Cancer
- (2015) Mian Xie et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Role of Notch Receptors in Transcriptional Regulation
- (2015) Hongfang Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Control of peripheral tolerance by regulatory T cell–intrinsic Notch signaling
- (2015) Louis-Marie Charbonnier et al. NATURE IMMUNOLOGY
- Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors
- (2015) Ashvinikumar V. Gavai et al. ACS Medicinal Chemistry Letters
- Gastric tumor-initiating CD44+ cells and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT
- (2015) LU-CHUN LI et al. Oncology Letters
- Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis
- (2015) Xun Yuan et al. Scientific Reports
- Nuclear Notch3 Expression is Associated with Tumor Recurrence in Patients with Stage II and III Colorectal Cancer
- (2014) Tsuyoshi Ozawa et al. ANNALS OF SURGICAL ONCOLOGY
- A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
- (2014) I Brana et al. BRITISH JOURNAL OF CANCER
- Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933
- (2014) Sylvia M. Lee et al. CANCER
- A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral -Secretase Inhibitor PF-03084014
- (2014) W. A. Messersmith et al. CLINICAL CANCER RESEARCH
- Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling
- (2014) MINGYI WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
- (2014) Ana De Jesus-Acosta et al. INVESTIGATIONAL NEW DRUGS
- A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors
- (2014) Noelle K. LoConte et al. INVESTIGATIONAL NEW DRUGS
- Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β-catenin signaling pathways
- (2014) WEI XIAO et al. Molecular Medicine Reports
- Three-dimensional structure of human γ-secretase
- (2014) Peilong Lu et al. NATURE
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer
- (2014) R. A. Sierra et al. Cancer Immunology Research
- γ-Secretase inhibitors and modulators
- (2013) Todd E. Golde et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients
- (2013) P A Candy et al. BRITISH JOURNAL OF CANCER
- Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
- (2013) J J Arcaroli et al. BRITISH JOURNAL OF CANCER
- A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)
- (2013) S Sahebjam et al. BRITISH JOURNAL OF CANCER
- Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
- (2013) Jia Lu et al. CANCER CELL
- Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
- (2013) Ingrid Espinoza et al. CANCER LETTERS
- Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer
- (2013) Shinichi Yabuuchi et al. CANCER LETTERS
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
- (2013) Nidhi Gupta et al. GYNECOLOGIC ONCOLOGY
- A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
- (2013) Ivan Diaz-Padilla et al. INVESTIGATIONAL NEW DRUGS
- A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
- (2013) Suzanne Richter et al. INVESTIGATIONAL NEW DRUGS
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor-Initiating Cells
- (2013) Norihiko Saito et al. STEM CELLS
- Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
- (2013) Cathy C. Zhang et al. Stem Cells Translational Medicine
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
- (2012) H Mizugaki et al. BRITISH JOURNAL OF CANCER
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- A phase II study of RO4929097 in metastatic colorectal cancer
- (2012) Jonathan R. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- Notch signaling mediates TGF-β1-induced epithelial–mesenchymal transition through the induction of Snai1
- (2012) Yosuke Matsuno et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
- (2012) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential Effects between -Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
- (2012) Y. Mitani et al. JOURNAL OF NEUROSCIENCE
- Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway
- (2012) He Wang et al. MODERN PATHOLOGY
- The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models
- (2012) M. Mizuma et al. MOLECULAR CANCER THERAPEUTICS
- Non-canonical Notch signaling: emerging role and mechanism
- (2012) Peter Andersen et al. TRENDS IN CELL BIOLOGY
- What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us
- (2011) Nina F. Schor ANNALS OF NEUROLOGY
- Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer
- (2011) D. Chu et al. ANNALS OF ONCOLOGY
- Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells
- (2011) Yi-Yang Hu et al. BMC CANCER
- Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
- (2011) T. S. Zhu et al. CANCER RESEARCH
- γ-Secretase inhibitor, DAPT inhibits self-renewal and stemness maintenance of ovarian cancer stem-like cells in vitro
- (2011) Li-yu Jiang et al. Chinese Journal of Cancer Research
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
- (2011) V Ramakrishnan et al. LEUKEMIA
- High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097
- (2011) Wei He et al. Molecular Oncology
- Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer
- (2011) M Kondratyev et al. ONCOGENE
- The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
- (2011) Chanh Huynh et al. PLoS One
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma
- (2011) Feng Chen et al. CELLULAR ONCOLOGY
- Novel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease
- (2010) Bart De Strooper et al. Annual Review of Cell and Developmental Biology
- Downregulation of Notch Pathway by a -Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model
- (2010) C. L. Efferson et al. CANCER RESEARCH
- Acute -Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid- Production to Alternative APP Fragments without Amyloid- Rebound
- (2010) J. J. Cook et al. JOURNAL OF NEUROSCIENCE
- Evaluation of Selective -Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
- (2010) P. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells
- (2010) M. Mazzone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor
- (2010) Kevin W. Gillman et al. ACS Medicinal Chemistry Letters
- Alzheimer’s disease and Notch signaling
- (2009) Ha-Na Woo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells
- (2009) S. S. Rao et al. CANCER RESEARCH
- Preclinical Profile of a Potent -Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
- (2009) L. Luistro et al. CANCER RESEARCH
- -Secretase Inhibitors Abrogate Oxaliplatin-Induced Activation of the Notch-1 Signaling Pathway in Colon Cancer Cells Resulting in Enhanced Chemosensitivity
- (2009) R. D. Meng et al. CANCER RESEARCH
- z-Leucinyl-Leucinyl-Norleucinal Induces Apoptosis of Human Glioblastoma Tumor-Initiating Cells by Proteasome Inhibition and Mitotic Arrest Response
- (2009) M. Monticone et al. MOLECULAR CANCER RESEARCH
- Emerging role of Notch in stem cells and cancer
- (2008) Zhiwei Wang et al. CANCER LETTERS
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Substrate specificity of γ-secretase and other intramembrane proteases
- (2008) A. J. Beel et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The many facets of Notch ligands
- (2008) B D'Souza et al. ONCOGENE
- Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1
- (2008) L. Sang et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More